These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11450990)

  • 1. Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.
    Hanada K; Nishijima K; Ogata H; Atagi S; Kawahara M
    Jpn J Clin Oncol; 2001 May; 31(5):179-84. PubMed ID: 11450990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.
    Urien S; Brain E; Bugat R; Pivot X; Lochon I; Van ML; Vauzelle F; Lokiec F
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):55-60. PubMed ID: 15258698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients.
    Nagai N; Kinoshita M; Ogata H; Tsujino D; Wada Y; Someya K; Ohno T; Masuhara K; Tanaka Y; Kato K; Nagai H; Yokoyama A; Kurita Y
    Cancer Chemother Pharmacol; 1996; 39(1-2):131-7. PubMed ID: 8995510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: analysis with the NONMEM program.
    Nagai N; Ogata H; Wada Y; Tsujino D; Someya K; Ohno T; Masuhara K; Tanaka Y; Takahashi H; Nagai H; Kato K; Koshiba Y; Igarashi T; Yokoyama A; Kinameri K; Kato T; Kurita Y
    J Clin Pharmacol; 1998 Nov; 38(11):1025-34. PubMed ID: 9824784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
    Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
    Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
    Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
    Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin.
    Figg WD; Christian MC; Lush R; Link CJ; Davis P; Kohn E; Sarosy G; Rothenberg ML; Weiss RB; Ryan N; Jacobs J; Reed E
    Biopharm Drug Dispos; 1997 May; 18(4):347-59. PubMed ID: 9158882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
    van der Vijgh WJ; Elferink F; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall HE; Simonetti G; McVie JG; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):621-7. PubMed ID: 3383966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.
    Urien S; Lokiec F
    Br J Clin Pharmacol; 2004 Jun; 57(6):756-63. PubMed ID: 15151521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin.
    Griffiths H; Shelley MD; Fish RG
    Eur J Clin Pharmacol; 1987; 33(1):67-72. PubMed ID: 3691598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
    Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
    Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of cisplatin in adult cancer patients.
    de Jongh FE; Gallo JM; Shen M; Verweij J; Sparreboom A
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):105-12. PubMed ID: 15127229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach.
    Morazzoni F; Canevali C; Zucchetti M; Caroli S; Alimonti A; Petrucci F; Giudice G; Masoni E; Bedini AV
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):37-43. PubMed ID: 9498833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin pharmacokinetics in children with cancer.
    Peng B; English MW; Boddy AV; Price L; Wyllie R; Pearson AD; Tilby MJ; Newell DR
    Eur J Cancer; 1997 Oct; 33(11):1823-8. PubMed ID: 9470840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum pharmacokinetics in sulphur-crested cockatoos (Cacatua galerita) following single-dose cisplatin infusion.
    Filippich LJ; Bucher AM; Charles BG
    Aust Vet J; 2000 Jun; 78(6):406-11. PubMed ID: 10920780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.